Esophageal Temperature During PVI Using Q-DOT Micro

Status Recruiting

Clinical Trial Summary

This study will assess how two different ablation strategies, using two different ablation catheters during catheter ablation for paroxysmal atrial fibrillation, affect the temperature of the esophagus during ablation, and the risk of injury to the esophagus.

Clinical Trial Description

This is a prospective randomized controlled trial, studying patients undergoing ablation involving pulmonary vein isolation for paroxysmal atrial fibrillation. Patients will be assigned to undergo conventional high-power short-duration ablation or temperature-controlled very-high-power short-duration ablation, and esophageal outcomes including temperature changes during ablation and esophageal injury as assessed by post-procedure capsule endoscopy will be compared between the groups. The hypothesis is that very-high-power short-duration ablation will lead to lower rises in esophageal temperature and lower rates of esophageal findings during capsule endoscopy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06392932
Study type	Interventional
Source	Cedars-Sinai Medical Center
Contact	Eric D Braunstein, MD
Phone	310-248-6679
Email	Eric.Braunstein@cshs.org
Status	Recruiting
Phase	N/A
Start date	June 2024
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06085014` - Clinical and Electrophysiological Predictors of Arrhythmic Recurrence in Patients With Paroxysmal AF Undergoing First Ablation Procedure of AF by Pulmonary Vein Isolation
Recruiting	`NCT03724383` - Atrial Fibrillation Lifestyle Project	N/A
Active, not recruiting	`NCT04544397` - Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
Not yet recruiting	`NCT05940597` - Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation	N/A
Not yet recruiting	`NCT04447300` - Outcomes of High Power Application in Catheter Ablation of Paroxysmal Atrial Fibrillation Guided by Unipolar Signal Modification.	N/A
Recruiting	`NCT05251545` - Randomized Trial: High Power Short Duration Versus Ablation Index	N/A
Recruiting	`NCT05883631` - RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.	N/A
Not yet recruiting	`NCT04600713` - Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.	N/A
Enrolling by invitation	`NCT05725187` - Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation
Recruiting	`NCT04606693` - Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates	N/A
Recruiting	`NCT05328882` - Early Recurrences of Atrial Arrhythmias and Their Impact on Late Recurrence After Pulmonary Vein Isolation With Pulsed Field Ablation of Paroxysmal Atrial Fibrillation
Recruiting	`NCT04342312` - Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
Recruiting	`NCT05549752` - Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia	Phase 3
Completed	`NCT03323099` - Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation	N/A
Completed	`NCT05461859` - Cardioneuroablation for the Treatment of Vagally-mediated Atrial Fibrillation.
Enrolling by invitation	`NCT04634461` - The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.
Completed	`NCT04023461` - Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients	Phase 4
Not yet recruiting	`NCT06364215` - Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation	N/A
Recruiting	`NCT05292209` - RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring	Phase 2
Completed	`NCT04511520` - Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF	N/A